MGRX NASDAQ
Mangoceuticals, Inc.
1W: -6.2%
1M: +13.8%
3M: -0.5%
YTD: -48.8%
1Y: -79.3%
3Y: -96.8%
$0.44
-0.04 (-9.03%)
Weekly Expected Move ±16.8%
$0
$0
$0
$1
$1
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
31 relationships31
As Filer
counterparties named
0
As Counterparty
mentioned by others
6
Rel. Types
2023-09-21
Earliest Filing
2025-12-19
Latest Filing
partner: 10
customer: 5
target: 5
supplier: 4
acquirer: 4
investor: 3
Counterparties (Filed by MGRX)
31 relationshipsCompanies named in MGRX's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Mango DAT, LLC | — | customer | Client party entering into Master Service Agreement for asset management services | 2025-12-19 | View |
| Cube Operations LLC | — | supplier | Service provider and Asset Manager party entering into Master Service Agreement | 2025-12-19 | View |
| SVHQ, LLC | — | partner | Landlord in the commercial lease agreement for office space. | 2025-10-29 | View |
| Mangoceuticals, Inc | MGRX | partner | Tenant in the commercial lease agreement for office space. | 2025-10-29 | View |
| Mangoceuticals, Inc. | MGRX | acquirer | Company entering into mutual rescission and release agreement to unwind Master Distribution Agreement. | 2025-08-04 | View |
| Navy Wharf, Ltd. | — | target | Counterparty entering into mutual rescission and release agreement to unwind Master Distribution Agreement. | 2025-08-04 | View |
| Mangoceuticals, Inc. | MGRX | partner | Party to mutual rescission and release agreement regarding consulting agreement and stock shares | 2025-05-23 | View |
| Mangoceuticals, Inc. | MGRX | acquirer | Purchaser acquiring intellectual property assets | 2025-04-25 | View |
| Smokeless Technology Corp. | — | target | Seller of intellectual property assets | 2025-04-25 | View |
| Harbour Importation Solutions Inc. | — | supplier | Provider of North American rights to coca leaf extract | 2025-04-25 | View |
| Tilray | TLRY | partner | Former employer of Greg Engel, referenced in advisory context | 2025-04-25 | View |
| British American Tobacco | BTAFF | partner | Company brought into OrganiGram by Greg Engel, referenced in advisory context | 2025-04-25 | View |
| OrganiGram | OGI | partner | Company associated with Greg Engel's advisory work | 2025-04-25 | View |
| Mangoceuticals, Inc. | MGRX | acquirer | Company entering consulting agreement | 2025-02-19 | View |
| 6330 Investment & Consulting Gmbh | — | partner | Consultant providing strategic business advisory services | 2025-02-19 | View |
| Mangoceuticals, Inc. | MGRX | customer | Agreed to make payments to Intramont Technologies for patent portfolio development and commercialization. | 2025-02-12 | View |
| Greenfield Investments, Ltd | — | target | Seller assigning patents to Mangoceuticals, Inc. | 2024-12-19 | View |
| Mangoceuticals, Inc. | MGRX | acquirer | Purchaser acquiring patents from Greenfield Investments, Ltd. | 2024-12-19 | View |
| Greentree Financial Group, Inc. | — | supplier | Consulting firm engaged to provide professional services including compliance filings, accounting review, and tax return | 2024-12-06 | View |
| Mangoceuticals, Inc. | MGRX | customer | Texas Corporation engaging Greentree Financial Group, Inc. for professional services and paying fees in cash and stock. | 2024-12-06 | View |
| Mangoceuticals, Inc. | MGRX | customer | Borrower of $150,000 promissory note | 2024-10-22 | View |
| Mangoceuticals, Inc. | MGRX | target | Company issuing stock and warrants in a multi-closing transaction | 2024-07-02 | View |
| Platinum Point Capital LLC | — | investor | Purchaser acquiring stock and warrants in a multi-closing transaction | 2024-07-02 | View |
| Mangoceuticals, Inc. | MGRX | target | Company issuing shares in the offering | 2023-12-19 | View |
| Olshan Frome Wolosky LLP | — | partner | Representative's counsel handling closing logistics | 2023-12-19 | View |
| M&K CPAS, PLLC | — | investor | Former auditor providing financial statements | 2023-12-19 | View |
| Turner, Stone & Company, L.L.P. | — | investor | New auditor providing financial statements | 2023-12-19 | View |
| Marius Pharmaceuticals | — | partner | Pharmaceutical manufacturer entering marketing agreement | 2023-12-11 | View |
| Mangoceuticals, Inc. | MGRX | partner | Men's Health platform acquiring marketing license | 2023-12-11 | View |
| Mangoceuticals, Inc. | MGRX | customer | Company engaging Epiq Scripts for pharmacy consulting services | 2023-09-21 | View |
| Epiq Scripts, LLC | — | supplier | Consultant providing pharmacy consulting services to Mangoceuticals | 2023-09-21 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-10-01 | Material Agreement; Acquisition/Disposition; Unregistered Equity Sales; Regulation FD; Exhibits | Agreement Acquisition | View |
| 2026-08-21 | Termination of Agreement; Exhibits | View | |
| 2026-07-30 | Material Agreement; Officer/Director Change; Bylaws Amendment; Regulation FD; Exhibits | Agreement | View |
| 2026-07-02 | Material Agreement; Unregistered Equity Sales; Exhibits | Agreement | View |
| 2026-03-17 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem | View | |
| 2026-02-23 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2026-02-19 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2026-02-06 | Notice of Delisting or Transfer | View | |
| 2025-12-19 | Entry into Material Definitive Agreement; Other Events; Financial Statements and Exhibits | Agreement | View |
| 2025-12-19 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Financial Stateme | Agreement | View |
| 2025-12-10 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Financial Stateme | Agreement | View |
| 2025-11-14 | Other Events; Financial Statements and Exhibits | View | |
| 2025-11-13 | Other Events; Financial Statements and Exhibits | View | |
| 2025-10-29 | Entry into Material Definitive Agreement; Termination of Material Definitive Agreement; Creation of | Agreement | View |
| 2025-09-12 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2025-09-02 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Financial Stateme | Agreement | View |
| 2025-08-04 | Entry into Material Definitive Agreement; Termination of Material Definitive Agreement; Completion o | Agreement Acquisition | View |
| 2025-07-23 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Financial Stateme | Agreement | View |
| 2025-07-10 | Amendments to Articles of Incorporation or Bylaws; Financial Statements and Exhibits | View | |
| 2025-07-03 | Departure/Election of Directors; Appointment of Officers | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR